BE667697A - - Google Patents

Info

Publication number
BE667697A
BE667697A BE667697A BE667697A BE667697A BE 667697 A BE667697 A BE 667697A BE 667697 A BE667697 A BE 667697A BE 667697 A BE667697 A BE 667697A BE 667697 A BE667697 A BE 667697A
Authority
BE
Belgium
Application number
BE667697A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB30327/64A external-priority patent/GB1109631A/en
Application filed filed Critical
Publication of BE667697A publication Critical patent/BE667697A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47F—SPECIAL FURNITURE, FITTINGS, OR ACCESSORIES FOR SHOPS, STOREHOUSES, BARS, RESTAURANTS OR THE LIKE; PAYING COUNTERS
    • A47F5/00—Show stands, hangers, or shelves characterised by their constructional features
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F5/00—Means for displaying samples
BE667697A 1964-07-31 1965-07-30 BE667697A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB30327/64A GB1109631A (en) 1964-07-31 1964-07-31 Derivatives of rifamycin sv
FR63914A FR5518M (xx) 1964-07-31 1966-06-02

Publications (1)

Publication Number Publication Date
BE667697A true BE667697A (xx) 1965-11-16

Family

ID=26171063

Family Applications (1)

Application Number Title Priority Date Filing Date
BE667697A BE667697A (xx) 1964-07-31 1965-07-30

Country Status (13)

Country Link
US (1) US3342810A (xx)
BE (1) BE667697A (xx)
BR (1) BR6571577D0 (xx)
CH (1) CH458353A (xx)
DE (1) DE1595883A1 (xx)
DK (1) DK115993B (xx)
FI (1) FI45044C (xx)
FR (2) FR5518M (xx)
IL (1) IL23930A (xx)
NL (1) NL6509961A (xx)
NO (1) NO118375B (xx)
SE (3) SE329895B (xx)
YU (2) YU32700B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795741A1 (de) * 1967-06-07 1974-05-30 Lepetit Spa Verfahren zur herstellung eines fuer die gewinnung von 3-formylrifamycin svderivaten geeigneten zwischenproduktes

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1165179A (en) * 1966-10-25 1969-09-24 Lepetit Spa Derivatives of Rifamycin SV
CH536851A (de) * 1966-10-25 1973-05-15 Ciba Geigy Ag Verfahren zur Herstellung neuer antibiotisch wirksamer Verbindungen der Rifamycinreihen
GB1159267A (en) * 1966-11-03 1969-07-23 Lepetit Spa Rifamycin Derivatives
FR2059967A1 (xx) * 1969-08-06 1971-06-11 Lepetit Spa
IL39305A (en) * 1971-06-07 1975-08-31 Lepetit Spa O-substituted oximes of 3-formylrifamycin sv
US3933800A (en) * 1971-06-07 1976-01-20 Gruppo Lepetit S.P.A. New 3-formylrifamycin SV derivatives
GB1336399A (en) * 1971-06-24 1973-11-07 Lepetit Spa 3-formylrifamycin sv derivatives
US4005076A (en) * 1971-06-24 1977-01-25 Gruppo Lepetit S.P.A. Hydrazones of 3-formylrifamycin SV
BE794100A (fr) * 1972-02-23 1973-05-16 Lepetit Spa Derives 3-hydrazonomethyles de rifamycine et leur preparation
AR205434A1 (es) * 1972-03-27 1976-05-07 Lepetit Spa Proceso para la preparacion de 3-acilhidrazonometil rifamicinas sv
AR207763A1 (es) * 1973-07-25 1976-10-29 Archifar Ind Chim Trentino Metodo para la preparacion de 1,3-oxacino(5,6-c)rifamicinas
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
IT1056271B (it) * 1975-05-20 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
US4150023A (en) * 1977-07-01 1979-04-17 Intreprinderea De Antibiotice Iasi Hydrosoluble rifamycins and process for their preparation
GB1594134A (en) * 1977-11-25 1981-07-30 Holco Investment Inc Rifamycins
IT1090771B (it) * 1977-12-20 1985-06-26 Alfa Farmaceutici Spa Derivati delle 3 carbossirifamicines ed sv e procedimento per la loro preparazione
IT1090772B (it) * 1977-12-20 1985-06-26 Alfa Farmaceutici Spa Derivati della rifamicina e procedimento per la loro preparazione
GB1591697A (en) * 1978-03-09 1981-06-24 Archifar Lab Chim Farm Process for producing 3-amino-rifamycins s and sv
US4220657A (en) * 1978-08-11 1980-09-02 Johnson Lewis A Method for treatment of human eye disease
US4292327A (en) * 1978-08-11 1981-09-29 Johnson Lewis A Method for treatment of human eye disease
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione
GB8308166D0 (en) * 1983-03-24 1983-05-05 Erba Farmitalia Preparation of azinomethyl-rifamycins
GB8318072D0 (en) * 1983-07-04 1983-08-03 Lepetit Spa Water-soluble rifampicin derivatives
MC1617A1 (fr) * 1983-09-01 1985-07-18 Ciba Geigy Ag Nouvelles hydrazones polycycliques,procede pour leur preparation
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4551450A (en) * 1984-08-27 1985-11-05 Ciba-Geigy Corporation Rifamycin hydrazones, pharmaceutical compositions containing them and their use
US4743619A (en) * 1985-08-29 1988-05-10 American Home Products Corporation Method of treating hepatitis
US4631290A (en) * 1985-08-29 1986-12-23 American Home Products Corporation Method of treating hepatitis
JPS63501712A (ja) * 1985-10-18 1988-07-14 チバ−ガイギ− アクチエンゲゼルシヤフト 置換４−ベンジルピペラジニル化合物
US4876258A (en) * 1987-08-13 1989-10-24 Ciba-Geigy Corporation Biphenylyl compounds
KR890701591A (ko) * 1987-09-25 1989-12-21 베르너 발데그 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides
AU5588598A (en) * 1996-11-19 1998-06-10 Georgetown University Heregulin antagonists and methods for their use
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
CA2618741C (en) 2005-08-11 2014-03-25 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
US7678791B2 (en) * 2006-07-12 2010-03-16 Cumbre Ip Ventures, L.P. Nitroheteroaryl-containing rifamycin derivatives
WO2009137380A1 (en) * 2008-05-05 2009-11-12 Janssen Pharmaceutica Nv 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
ES2687027T3 (es) 2010-11-08 2018-10-23 Albireo Ab Inhibidores de ibat para el tratamiento de enfermedades hepáticas
JP6867288B2 (ja) 2014-07-21 2021-04-28 エーエムディー セラピューティックス エルエルシー リファマイシンの眼科用組成物およびその使用
US11702443B2 (en) * 2016-10-04 2023-07-18 Pop Test Oncology Llc Therapeutic agents and methods
EP3534910A4 (en) 2016-10-04 2020-11-25 Pop Test Oncology LLC THERAPEUTICS AND PROCEDURES

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795741A1 (de) * 1967-06-07 1974-05-30 Lepetit Spa Verfahren zur herstellung eines fuer die gewinnung von 3-formylrifamycin svderivaten geeigneten zwischenproduktes

Also Published As

Publication number Publication date
NL6509961A (xx) 1966-02-01
CH458353A (fr) 1968-06-30
IL23930A (en) 1969-04-30
YU31937B (en) 1974-02-28
FI45044C (fi) 1972-03-10
DE1595883A1 (de) 1970-02-12
NO118375B (xx) 1969-12-22
FR5518M (xx) 1967-11-06
BR6571577D0 (pt) 1973-08-14
YU32700B (en) 1975-06-30
SE329851B (xx) 1970-10-26
DK115993B (da) 1969-12-01
US3342810A (en) 1967-09-19
FI45044B (xx) 1971-11-30
FR208F (xx)
YU1268A (en) 1974-12-31
SE329850B (xx) 1970-10-26
YU1168A (en) 1973-08-31
SE329895B (xx) 1970-10-26

Similar Documents

Publication Publication Date Title
BE648757A (xx)
AU442366B2 (xx)
BE642530A (xx)
BE636791A (xx)
BE660021A (xx)
BE659404A (xx)
BE659255A (xx)
BE658586A (xx)
BE656197A (xx)
NL6504053A (xx)
BE655801A (xx)
BE660944A (xx)
BE642973A (xx)
BE642797A (xx)
BE642770A (xx)
BE660951A (xx)
BE642741A (xx)
BE642735A (xx)
BE642654A (xx)
BE642652A (xx)
BE642589A (xx)
BE642588A (xx)
BE667697A (xx)
BE622126A (xx)
BE628611A (xx)